Overexpression of PIWIL1 leads to resistance of MM cells after treatment with chemotherapeutic drugs, whereas its downregulation leads to re-sensitization of MM cells to chemotherapy. The gene discussed is PIWIL1; the disease is Miyoshi myopathy.